GM Food is Safe
Assessment of GMO applications
EFSA evaluates the safety of new GMO products before a market authorisation decision is taken by risk managers. This evaluation encompasses the assessment of the potential impact of GMOs on human health, animal health and the environment. EFSA’s assessments are based on scientific dossiers presented by applicants and any other relevant scientific information.
EFSA applies the principles of GMO risk assessment considering the following aspects:
- Molecular characterisation: assessment of the molecular structure of the newly created proteins, their functioning and their potential interactions.
- Comparative analysis: comparison of the GM plant with its conventional counterpart. The aim is to detect differences in the plant’s observable appearance such as height and colour – phenotypic characteristics – and its agronomic characteristics such as yield. The analysis also compares the nutritional values of the GM plant and its conventional counterpart.
- Evaluation of potential toxicity and allergenicity.
- Evaluation of potential environmental impact.
Once a GMO has been authorised by risk managers, it normally receives a 10-year licence for the EU market. After 10 years, it must be re-assessed by EFSA before any re-authorisation decision is taken.
Read Full News Story » Should Europe Embrace GM Food on Economic Grounds?
